Arkolith/Insider Trading/IMGO/Form 4

Eichorn Laura G.

Chief Financial OfficerImago BioSciences, Inc. (IMGO) · full profile →Form 4 · filed Jan 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Option exercise(M)23K$2.52$58K232K
Jan 3, 2023Option exercise(M)2K$22.76$40K246K
Jan 3, 2023Option exercise(M)12K$4.20$52K245K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2023Option exercise(M)2K—$0101K
Jan 3, 2023Option exercise(M)12K—$011K
Jan 3, 2023Option exercise(M)23K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-000460) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML